CD8A and neoplasm: However, it is unclear whether the presence of tumor cells within draining LN accounts for this difference or whether the effector differentiation of CD8+ T cells observed early after tumor challenge reflects a difference in responsiveness to recently injected cells versus those associated with an established tumor.